Madison, WI – According to filings with the U.S. Securities and Exchange Commission, Atrility Medical is raising $3,837,995.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, David Kaysen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Atrility Medical

Atrility Medical (Madison, WI) is focused on cardiac health and improving the lives of patients through advances in medical technology. Our desire is to bring cardiac medical devices to market by closely integrating healthcare, business, and engineering specialists. Up to 60% of pediatric patients experience arrhythmias after heart surgery. Increased length of stay places high burden on the patient and hospital. Surface electrode signals are often not sufficient in diagnosis of atrial arrhythmias. Current practice is time consuming to create short atrial electrogram printout. The AtriAmp facilitates monitoring and treatment of atrial arrhythmias by providing a continuous atrial electrogram.

To learn more about Atrility Medical, visit http://atrility.com/

Contact:
David Kaysen, President and Chief Executive Officer
608-960-9960
https://www.linkedin.com/in/davidkaysen/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved